Table 2.
Multivariate regression for the effect of baseline baPWV on the development of incident hypertension.
| Variables | N | Incidence, % | Crude model | Adjusted model 1 | Adjusted model 2 | |||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |||
| baPWV continuous, per 1 m/s increase | ||||||||
| 1849 | 248 (13.41%) | 1.23 (1.17, 1.28) | <0.001 | 1.22 (1.15, 1.28) | <0.001 | 1.14 (1.07, 1.20) | <0.001 | |
|
| ||||||||
| baPWV categories, cm/s | ||||||||
| Q1 (<1311) | 466 | 21 (4.59%) | 1 (reference) | 1 (reference) | 1 (reference) | |||
| Q2 (≥1311 − <1451) | 462 | 45 (9.74%) | 2.25 (1.32, 3.83) | 0.003 | 2.15 (1.26, 3.68) | 0.005 | 1.67 (0.95, 2.94) | 0.076 |
| Q3 (≥1451 − <1622) | 466 | 72 (15.45%) | 3.80 (2.30, 6.30) | <0.001 | 3.50 (2.09, 5.87) | <0.001 | 2.05 (1.18, 3.55) | 0.010 |
| Q4 (≥1622) | 463 | 110 (23.76%) | 6.48 (3.98, 10.56) | <0.001 | 5.49 (3.24, 9.28) | <0.001 | 2.72 (1.54, 4.78) | <0.001 |
| P for trend | <0.001 | <0.001 | ||||||
baPWV, brachial-ankle pulse wave velocity; OR, odds ratio; CI, confidence interval. Model 1, adjusted for age and sex; Model 2, adjusted for variables in model 1 and body mass index, current smoking, current drinking, baseline systolic blood pressure and estimated glomerular filtration rate, diabetes mellitus, dyslipidemia, history of cardiovascular disease, hypoglycemic agents, and lipid-lowering agents.